comparemela.com

Latest Breaking News On - Biosciences holdings - Page 7 : comparemela.com

Form N-CSRS HUSSMAN INVESTMENT TRUST For: Dec 31

Form N-CSRS HUSSMAN INVESTMENT TRUST For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Wisconsin
United-states
Hawaii
Cincinnati
Ohio
Ellicott-city
Maryland
Washington
Canada
New-york
Philadelphia
Pennsylvania

Mizuho Lowers Harmony Biosciences (NASDAQ:HRMY) Price Target to $40.00

Harmony Biosciences (NASDAQ:HRMY – Get Free Report) had its price target dropped by investment analysts at Mizuho from $42.00 to $40.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Mizuho’s target price suggests a potential upside of 20.26% from the company’s previous close. […]

United-states
America
Raymond-james
Goldman-sachs-group
Barclays-plc
Harmony-biosciences-holdings-inc
Cantor-fitzgerald
Voloridge-investment-management
Pricet-rowe-associates-inc
Needham-company
Harmony-biosciences
Get-free-report

Harmony Biosciences (NASDAQ:HRMY) Given "Overweight" Rating at Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) in a report published on Friday morning, Benzinga reports. The brokerage currently has a $49.00 price objective on the stock. Other equities research analysts have also recently issued reports about the stock. The Goldman Sachs Group increased their price objective […]

United-states
America
Raymond-james
Citigroup-inc
Harmony-biosciences-holdings-inc
Goldman-sachs-group
Needham-company
Cantor-fitzgerald
Metlife-investment-management
Acadian-asset-management
York-mellon-corp
Jpmorgan-chase-co

Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% After Earnings Miss

Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) fell 5.8% during mid-day trading on Thursday following a weaker than expected earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 […]

United-states
China
America
Raymond-james
Harmony-biosciences-holdings-inc
China-universal-asset-management-co
Nasdaq
Harmony-biosciences-company-profile
Lazard-asset-management
Wealth-partners
Quadrant-capital-group
Cantor-fitzgerald

Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% Following Weak Earnings

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) traded down 5.8% during mid-day trading on Thursday following a dissappointing earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 shares. The stock […]

China
United-states
Raymond-james
Nasdaq
Lazard-asset-management
Harmony-biosciences-holdings-inc
China-universal-asset-management-co
Life-insurance-co
Goldman-sachs-group
Cantor-fitzgerald
Quadrant-capital-group
Wealth-partners

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.